Advertisement
Singapore markets closed
  • Straits Times Index

    3,307.90
    -6.15 (-0.19%)
     
  • Nikkei

    38,617.10
    -329.83 (-0.85%)
     
  • Hang Seng

    19,195.60
    -25.02 (-0.13%)
     
  • FTSE 100

    8,385.10
    -31.35 (-0.37%)
     
  • Bitcoin USD

    69,959.72
    -1,018.80 (-1.44%)
     
  • CMC Crypto 200

    1,500.15
    -26.27 (-1.72%)
     
  • S&P 500

    5,321.41
    +13.28 (+0.25%)
     
  • Dow

    39,872.99
    +66.22 (+0.17%)
     
  • Nasdaq

    16,832.62
    +37.75 (+0.22%)
     
  • Gold

    2,418.90
    -7.00 (-0.29%)
     
  • Crude Oil

    78.03
    -0.63 (-0.80%)
     
  • 10-Yr Bond

    4.4140
    -0.0230 (-0.52%)
     
  • FTSE Bursa Malaysia

    1,622.09
    -5.41 (-0.33%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,607.22
    -26.44 (-0.40%)
     

Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast

BURLINGTON, Mass., May 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings which ended on March 31, 2024, on Wednesday, May 8, 2024, after the market closes.

The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time. Conference call participants may access the call using the following online registration link. Registrants will receive a confirmation containing dial in details and a unique conference call code for entry. Analysts, investors, and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on May 9, 2024.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.

ADVERTISEMENT

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
ir@azenta.com

Sherry Dinsmore
sherry.dinsmore@azenta.com

Azenta logo (PRNewsfoto/Azenta)
Azenta logo (PRNewsfoto/Azenta)
Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-announces-fiscal-2024-second-quarter-earnings-conference-call-and-webcast-302133656.html

SOURCE Azenta